Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Bruce Michael Cohen, M.D.,Ph.D.

Co-Author

This page shows the publications co-authored by Bruce Cohen and Marc Kaufman.
Connection Strength

0.610
  1. Oral choline increases choline metabolites in human brain. Psychiatry Res. 2004 Jan 15; 130(1):1-9.
    View in: PubMed
    Score: 0.072
  2. Selective serotonin reuptake inhibitor discontinuation syndrome is associated with a rostral anterior cingulate choline metabolite decrease: a proton magnetic resonance spectroscopic imaging study. Biol Psychiatry. 2003 Sep 01; 54(5):534-9.
    View in: PubMed
    Score: 0.070
  3. Cocaine-induced cerebral vasoconstriction differs as a function of sex and menstrual cycle phase. Biol Psychiatry. 2001 May 01; 49(9):774-81.
    View in: PubMed
    Score: 0.060
  4. Cocaine pharmacokinetics in men and in women during the follicular and luteal phases of the menstrual cycle. Neuropsychopharmacology. 1999 Aug; 21(2):294-303.
    View in: PubMed
    Score: 0.053
  5. Cerebral phosphorus metabolite abnormalities in opiate-dependent polydrug abusers in methadone maintenance. Psychiatry Res. 1999 Jun 30; 90(3):143-52.
    View in: PubMed
    Score: 0.053
  6. Cocaine decreases relative cerebral blood volume in humans: a dynamic susceptibility contrast magnetic resonance imaging study. Psychopharmacology (Berl). 1998 Jul; 138(1):76-81.
    View in: PubMed
    Score: 0.049
  7. Concurrent pharmacokinetic analysis of plasma cocaine and adrenocorticotropic hormone in men. J Clin Endocrinol Metab. 1998 Mar; 83(3):966-8.
    View in: PubMed
    Score: 0.048
  8. Cocaine-induced cerebral vasoconstriction detected in humans with magnetic resonance angiography. JAMA. 1998 Feb 04; 279(5):376-80.
    View in: PubMed
    Score: 0.048
  9. In Vivo Brain Glycine and Glutamate Concentrations in Patients With First-Episode Psychosis Measured by Echo Time-Averaged Proton Magnetic Resonance Spectroscopy at 4T. Biol Psychiatry. 2018 03 15; 83(6):484-491.
    View in: PubMed
    Score: 0.047
  10. Cerebral blood volume and clinical changes on the third day of placebo substitution for SSRI treatment. Biol Psychiatry. 2003 Jan 01; 53(1):100-5.
    View in: PubMed
    Score: 0.017
  11. Influence of baseline hematocrit and hemodilution on BOLD fMRI activation. Magn Reson Imaging. 2001 Oct; 19(8):1055-62.
    View in: PubMed
    Score: 0.015
  12. Test-retest reliability of DSC MRI CBV mapping in healthy volunteers. Neuroreport. 2001 Jun 13; 12(8):1567-9.
    View in: PubMed
    Score: 0.015
  13. Proton magnetic resonance spectroscopy of human basal ganglia: response to cocaine administration. Biol Psychiatry. 2000 Oct 01; 48(7):685-92.
    View in: PubMed
    Score: 0.014
  14. Brain kinetics of paroxetine and fluoxetine on the third day of placebo substitution: a fluorine MRS study. Am J Psychiatry. 2000 Sep; 157(9):1506-8.
    View in: PubMed
    Score: 0.014
  15. Reduction in BOLD fMRI response to primary visual stimulation following alcohol ingestion. Psychiatry Res. 1998 Jun 30; 82(3):135-46.
    View in: PubMed
    Score: 0.012
  16. Abnormal cerebral metabolism in polydrug abusers during early withdrawal: a 31P MR spectroscopy study. Magn Reson Med. 1996 May; 35(5):658-63.
    View in: PubMed
    Score: 0.011
  17. Sequential dynamic susceptibility contrast MR experiments in human brain: residual contrast agent effect, steady state, and hemodynamic perturbation. Magn Reson Med. 1995 Nov; 34(5):655-63.
    View in: PubMed
    Score: 0.010
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.